Literature DB >> 22403010

A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.

Paige M Dexter1, Kim A Caldwell, Guy A Caldwell.   

Abstract

Ongoing investigations into causes and cures for human movement disorders are important toward the elucidation of diseases such as Parkinson's disease (PD) and dystonia. The use of animal model systems can provide links to susceptibility factors, as well as therapeutic interventions. In this regard, the nematode roundworm, Caenorhabditis elegans, is ideal for examining age-dependent neurodegenerative disease studies. It is genetically tractable, has a short lifespan, and a well-defined nervous system. Green fluorescent protein is readily visualized in C. elegans because it is a transparent organism, thus the nervous system and factors that alter the viability of neurons can be directly examined in vivo. Through expression of the human PD-associated protein (α-synuclein in the worm dopamine neurons), neurodegeneration is observed in an age-dependent manner. Furthermore, expression of the early-onset dystonia-related protein torsinA increases vulnerability to endoplasmic reticulum (ER) stress in C. elegans, because torsinA is located in the ER. Here we provide an overview of collaborative studies we have conducted that collectively demonstrate the usefulness of the nematode model to discern functional effectors of dopaminergic neurodegeneration and ER stress that translate to mammalian data in the fields of PD and dystonia. Taken together, the application of C. elegans toward the evaluation of genetic modifiers for movement disorders research has predictive value and serves to accelerate the path forward for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403010      PMCID: PMC3337026          DOI: 10.1007/s13311-012-0109-x

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  72 in total

1.  A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

Authors:  N Sharma; J Hewett; L J Ozelius; V Ramesh; P J McLean; X O Breakefield; B T Hyman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.

Authors:  Pooja Jadiya; Asif Khan; Shreesh Raj Sammi; Supinder Kaur; Snober S Mir; Aamir Nazir
Journal:  Biochem Biophys Res Commun       Date:  2011-09-08       Impact factor: 3.575

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 4.  Cell lineage and cell death: Caenorhabditis elegans and cancer research.

Authors:  Malia B Potts; Scott Cameron
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

5.  Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

Authors:  Evelyn Braungart; Manfred Gerlach; Peter Riederer; Ralf Baumeister; Marius C Hoener
Journal:  Neurodegener Dis       Date:  2004       Impact factor: 2.977

Review 6.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

7.  A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans.

Authors:  Andrew G Davies; Jonathan T Pierce-Shimomura; Hongkyun Kim; Miri K VanHoven; Tod R Thiele; Antonello Bonci; Cornelia I Bargmann; Steven L McIntire
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

8.  Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia.

Authors:  Neil J Risch; Susan B Bressman; Geetha Senthil; Laurie J Ozelius
Journal:  Am J Hum Genet       Date:  2007-04-27       Impact factor: 11.025

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity.

Authors:  Esti Yeger-Lotem; Laura Riva; Linhui Julie Su; Aaron D Gitler; Anil G Cashikar; Oliver D King; Pavan K Auluck; Melissa L Geddie; Julie S Valastyan; David R Karger; Susan Lindquist; Ernest Fraenkel
Journal:  Nat Genet       Date:  2009-02-22       Impact factor: 38.330

View more
  20 in total

1.  Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.

Authors:  Edward F Griffin; Xiaohui Yan; Kim A Caldwell; Guy A Caldwell
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

2.  Dihydropyrimidine-Thiones and Clioquinol Synergize To Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism.

Authors:  Daniel F Tardiff; Lauren E Brown; Xiaohui Yan; Richard Trilles; Nathan T Jui; M Inmaculada Barrasa; Kim A Caldwell; Guy A Caldwell; Scott E Schaus; Susan Lindquist
Journal:  ACS Chem Neurosci       Date:  2017-07-12       Impact factor: 4.418

Review 3.  Crossing the Worm-Brain Barrier by Using Caenorhabditis elegans to Explore Fundamentals of Human Psychiatric Illness.

Authors:  Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2018-01-11

4.  O-GlcNAc cycling shows neuroprotective potential in C. elegans models of neurodegenerative disease.

Authors:  John A Hanover; Peng Wang
Journal:  Worm       Date:  2013-11-12

5.  Phenazine derivatives cause proteotoxicity and stress in C. elegans.

Authors:  Arpita Ray; Courtney Rentas; Guy A Caldwell; Kim A Caldwell
Journal:  Neurosci Lett       Date:  2014-10-07       Impact factor: 3.046

6.  Caenorhabditis elegans Model Studies Show MPP+ Is a Simple Member of a Large Group of Related Potent Dopaminergic Toxins.

Authors:  David Murphy; Harshil Patel; Kandatege Wimalasena
Journal:  Chem Res Toxicol       Date:  2021-01-26       Impact factor: 3.739

7.  Conserved role of dopamine in the modulation of behavior.

Authors:  Andrés G Vidal-Gadea; Jonathan T Pierce-Shimomura
Journal:  Commun Integr Biol       Date:  2012-09-01

8.  Drug absorption efficiency in Caenorhbditis elegans delivered by different methods.

Authors:  Shan-Qing Zheng; Ai-Jun Ding; Guo-Ping Li; Gui-Sheng Wu; Huai-Rong Luo
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  Modulating Behavior in C. elegans Using Electroshock and Antiepileptic Drugs.

Authors:  Monica G Risley; Stephanie P Kelly; Kailiang Jia; Brock Grill; Ken Dawson-Scully
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

10.  The Prevalence and Distribution of Neurodegenerative Compound-Producing Soil Streptomyces spp.

Authors:  Anna L Watkins; Arpita Ray; Lindsay R Roberts; Kim A Caldwell; Julie B Olson
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.